Position in NVS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$234,133,519
-$15,295,092 QoQ
Shares Held
1,532,789
-15.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $4,292,776,815 across 12 Drug Manufacturers - General names. NVS ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,226,699 | $1,128,280,937 | |
| 2 | JNJ |
Johnson & Johnson
|
3,371,601 | $824,154,147 | |
| 3 | ABBV |
AbbVie Inc.
|
2,831,636 | $615,852,511 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,709,942 | $566,558,921 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,769,886 | $246,669,011 | |
| 6 | NVS |
Novartis AG
This page
|
1,532,789 | $234,133,519 | |
| 7 | AMGN |
Amgen Inc
|
626,393 | $220,396,376 | |
| 8 | PFE |
Pfizer Inc
|
6,339,372 | $178,009,564 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $234,133,519 | 1,532,789 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $249,428,611 | 1,809,158 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $267,834,367 | 2,088,540 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $277,340,398 | 2,291,880 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $266,773,757 | 2,393,019 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $236,164,168 | 2,426,926 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $284,049,710 | 2,469,568 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $264,187,409 | 2,481,565 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $244,082,097 | 2,523,334 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $253,298,188 | 2,508,648 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $258,649,532 | 2,539,265 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $251,051,365 | 2,487,874 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $251,191,924 | 2,730,347 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $223,718,876 | 2,466,037 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $186,850,137 | 2,458,231 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $191,745,823 | 2,268,376 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $201,220,139 | 2,293,107 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $199,273,541 | 2,278,193 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $169,167,163 | 2,068,564 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $152,095,163 | 1,666,979 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $158,092,439 | 1,674,176 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $134,102,407 | 1,542,116 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $129,038,998 | 1,477,433 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $118,762,876 | 1,440,423 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||